Baxter to buy Gambro? Analysts give cautious thumbs up
This article was originally published in Clinica
Unconfirmed media reports about Baxter mulling a $4 billion acquisition of Swedish kidney dialysis firm Gambro have driven shares in the Deerfield, Illinois company to their highest level in over four years. If true, the transaction would be the largest in Baxter's history and significantly expand its existing dialysis business.